RxDoctor Payments Data

Timothy Spurlin, APRN

Psychiatric/Mental Health · Conway, ARNPI 1386334902

Payments from drug & device makers

$1,126in general payments, 2019–2025

Across 68 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$268
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$236
  • Otsuka America Pharmaceutical, Inc.$218
  • Teva Pharmaceuticals USA, Inc.$118
  • Johnson & Johnson$94
  • Neurocrine Biosciences, Inc.$82
  • plus $110 from 3 others

What the payments were for

  • Food & beverage$1,126100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,126 in reported general payments places this provider in the 55th percentile of 359 psychiatric/mental health providers in Arkansas.

See all psychiatric/mental health providers in Arkansas

Medicare billing

Part B allowed, 2024
$17,279
Medicare patients
42
Services billed
190

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl29$44,741
RexultiBrexpiprazole12$19,498
Ziprasidone Hcl43$3,693
Lurasidone Hcl11$3,345
Vilazodone Hcl20$2,252
Duloxetine Hcl123$2,143
Aripiprazole62$1,418
Chlorpromazine Hcl12$1,308
Trazodone Hcl133$1,080
Clonazepam97$955
Buspirone Hcl77$808
Prazosin Hcl44$750
Bupropion XlBupropion Hcl64$545
Fluvoxamine Maleate14$524
Mirtazapine35$481

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$268$44,74129 claims
Otsuka America Pharmaceutical, Inc.Rexulti$218$19,49812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 359 psychiatric/mental health providers in Arkansas.

Other psychiatric/mental health in Conway

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →